novo nordisk lawsuit semaglutide is suing U.S. telehealth company Hims and Hers, alleging patent infringement over its planned release of a knockoff version of its Wegovy weight loss pill. Hims and Hers is pushing back, Novo Nordisk Settles Ozempic Patent

Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies

The GOAL-HF1 trial, investigating the safety and efficacy of ghrelin in patients with HFrEF, is currently ongoing and represents an important step toward determining the therapeutic potential of ghrelin in HF

Hobart shares that it can also flatten the rush someone might experience from something completely unrelated, like sex or an exciting life event

Supporting trend data: Nationwide GLP-1 access research published by Honest Care shows that over 50% of patients seeking GLP-1 coverage now face full formulary exclusions as insurers tighten policies heading into 2026

Please consult with us if you: Are pregnant or breastfeeding Have underlying health conditions Are taking certain medications Can this be part of a regular routine

Weeks 9 and beyond: Find your new sustainable baseline